Traneta M Tablet 2.5 mg + 500 mg is a combination oral antidiabetic medicine used for the management of type 2 diabetes mellitus in adults. It contains Linagliptin (2.5 mg) and Metformin Hydrochloride (500 mg), two complementary agents that work together to improve blood glucose control when diet and exercise alone are not sufficient.
This fixed-dose combination is particularly beneficial for patients who require dual therapy to achieve and maintain optimal glycemic control.
রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন
Linagliptin 2.5 mg
Metformin Hydrochloride 500 mg
Traneta M Tablet is indicated for:
Management of type 2 diabetes mellitus in adults
Improving glycemic control as an adjunct to diet and exercise
Patients inadequately controlled on metformin alone
Patients already receiving linagliptin and metformin as separate tablets
Antidiabetic agents (DPP-4 inhibitor + Biguanide)
Linagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor. It works by increasing the levels of incretin hormones, which stimulate insulin release and suppress glucagon secretion in a glucose-dependent manner. This helps lower blood glucose levels without significantly increasing the risk of hypoglycemia.
Metformin Hydrochloride is a biguanide that reduces hepatic glucose production, decreases intestinal absorption of glucose, and improves insulin sensitivity by increasing peripheral glucose uptake and utilization. It is considered the first-line therapy for type 2 diabetes due to its proven efficacy and safety profile.
The combination provides effective blood sugar control through complementary mechanisms of action.
রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন
The dosage should be individualized based on the patient’s glycemic control, tolerability, and prior therapy
Usually taken once or twice daily with meals to reduce gastrointestinal side effects
Follow the physician’s instructions carefully
Effective control of fasting and postprandial blood glucose
Low risk of hypoglycemia when used alone
Improves insulin sensitivity
Convenient fixed-dose combination improves patient compliance
Use with caution in patients with renal impairment
Not recommended in patients with severe renal dysfunction
Use during pregnancy and breastfeeding only if clearly needed and prescribed by a physician
Common side effects may include:
Nausea
Diarrhea
Abdominal discomfort
Headache
Serious but rare side effects may include lactic acidosis (associated with metformin), especially in patients with renal impairment.
Store in a cool and dry place
Protect from light and moisture
Keep out of reach of children
Regular monitoring of blood glucose and renal function is recommended
Avoid excessive alcohol intake
Inform your doctor about any other medications being taken.
Login Or Registerto submit your questions to seller
No none asked to seller yet